Onychomycosis Clinical Trial
— EPOCAONOfficial title:
Effectiveness of Supplementation With Nail Debridement in Ungual Lacquer Treatment in Podiatry Care on Onychomycosis: Pilot Study of Randomized Control Trial
NCT number | NCT00938925 |
Other study ID # | 03-2009 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | October 2009 |
Est. completion date | March 2017 |
Verified date | March 2010 |
Source | University of Malaga |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Onychomycosis occurs in more than 50% of all pathologies unguinal, affecting the health and
quality of life of the patient. Although the investigators have a wide therapeutic arsenal,
there is still a disparity when carrying out an effective processing.
Hypothesis/Objectives:
To analyze if the use of the podiatric technique of aggressive unguinal abrasion with
micrometer sports, in combination with topical treatment with amorolfin 5% in hairspray,
significantly increases the effectiveness clinically as well as mycology.
The investigators will analyze the relationship between this intervention and the quality
perception of life related to the health of the nails and the foot.
The investigators will Use results for next validation study in Spanish of the questionnaire
NailQoL, as well as validation and reliability of the index SCIO and cost study-effectiveness
of the processing.
Method:
The investigators will design a randomized control trial. The town will be recruited,
informed prior consent will be obtained from patients of 5 Spanish centers of chiropody, with
sample size of 313 patients. There will be a screening of 4 weeks to select patients with
onychomycosis infections (clinic and mycology both positives); later the patients will be
distributed randomly in 2 groups:
- GROUP AM+AU: Will be administered aggressive unguinal abrasion, weeks 0 (baseline), 12
and 24, followed by standard treatment of amorolfin 5%, two weekly applications during
36 weeks.
- GROUP AM: Will be administered exclusively standard treatment of amorolfin 5%, according
to common format. The duration will be 48 weeks.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | March 2017 |
Est. primary completion date | December 2013 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - People of both sexes with ages between 18 and 75 years. - Having affected at least the nail out of the first toe of a foot. - Having a confirmed diagnosis of onychomycosis with positive and evidence clinic mycology (KOH and Cultivation) both positive ones. - The infection should be caused by a fungus dermatology. Will not afford another type of infection because of the possibility of false positives for pollution exogen. Exclusion Criteria: - Having received in 6 previous months some local treatment or systemic for the onychomycosis. - Having dystrophies or alterations ungulates, apart from the ones specific to the onychomycosis, that could to interfere in the interpretation of results. - Do not have skills for the application and tracking of the topical treatment with the hairspray ungual. - Allergy to one of the ingredients of the nail lacquer - Pregnancy or breastfeeding situation acquaintances at the time of recruitment. - Use of some abrasive or cosmetic product (ej: nail paint) on the treated nail during the tracking of the study. - Receiving some type of attendance podology or of Pedicure out of the own ones included in the study. |
Country | Name | City | State |
---|---|---|---|
Spain | Antonio Cuesta-vargas | Malaga | |
Spain | Health Science School , University of Malaga | Malaga | |
Spain | School Health Sciences, University of Malaga | Malaga | Málaga |
Lead Sponsor | Collaborator |
---|---|
University of Malaga |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | (Potassium hydroxide) KOH and cultivation negative | pre and post intervention and 6 and 12 months of follow up | ||
Secondary | Clinical improvements of the onychomycosis, valued with SCIO (Scoring Clinical Index for Onychomycosis) | total score, pre and post intervention and 6 and 12 months of follow up | ||
Secondary | Quality of life perception related the onychomycosis and foot health by nailQoL and foot health state questionnaire (FHSQ) | total score, pre and post intervention and 6 and 12 months of follow up | ||
Secondary | Quality of life related general health by euroQol 5-D and SF-12 | total score, pre and post intervention and 6 and 12 months of follow up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03098615 -
Study Evaluating the Effect of Jublia on Dermatophytomas
|
Phase 4 | |
Recruiting |
NCT01666002 -
Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser
|
N/A | |
Terminated |
NCT01208129 -
Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails
|
Phase 3 | |
Completed |
NCT01180491 -
A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis
|
N/A | |
Terminated |
NCT01208168 -
Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails
|
Phase 3 | |
Completed |
NCT00385502 -
A Trial of the Safety and Efficacy of EcoNailâ„¢ in the Treatment of Fungus Infections of the Great Toenail
|
Phase 2 | |
Completed |
NCT00253305 -
Topical Gel Anti-Fungal Agent for Tinea Unguium
|
Phase 2 | |
Not yet recruiting |
NCT05809297 -
Diode Laser and Photodynamic Therapy Vs. Ciclopirox.
|
Phase 4 | |
Completed |
NCT03405818 -
An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents
|
Phase 4 | |
Completed |
NCT02588599 -
A Retrospective Analysis of the Effects of Low Level Laser Therapy on Toenail Onychomycosis
|
N/A | |
Recruiting |
NCT02436291 -
Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis
|
Phase 4 | |
Completed |
NCT01851590 -
Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis
|
Phase 4 | |
Completed |
NCT01452490 -
Diode Laser Treatment of Onychomycosis
|
N/A | |
Recruiting |
NCT00808366 -
Efficacy and Safety of RV4104A Ointment in Onychomycosis
|
N/A | |
Completed |
NCT00781820 -
Comparative Efficacy of Bifonazole Cream vs Placebo After Nail Ablation With Urea Paste
|
Phase 3 | |
Completed |
NCT00768768 -
Iontophoretic Application of Terbinafine Gel to the Large Toe Nail
|
Phase 1 | |
Completed |
NCT00777868 -
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis
|
Phase 2 | |
Recruiting |
NCT06074315 -
Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis
|
N/A | |
Completed |
NCT01039883 -
A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule
|
Phase 1 | |
Suspended |
NCT05491603 -
A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis
|
Phase 2 |